Correlation Between Nkarta and Avalo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nkarta and Avalo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nkarta and Avalo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nkarta Inc and Avalo Therapeutics, you can compare the effects of market volatilities on Nkarta and Avalo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nkarta with a short position of Avalo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nkarta and Avalo Therapeutics.

Diversification Opportunities for Nkarta and Avalo Therapeutics

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Nkarta and Avalo is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Nkarta Inc and Avalo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avalo Therapeutics and Nkarta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nkarta Inc are associated (or correlated) with Avalo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avalo Therapeutics has no effect on the direction of Nkarta i.e., Nkarta and Avalo Therapeutics go up and down completely randomly.

Pair Corralation between Nkarta and Avalo Therapeutics

Given the investment horizon of 90 days Nkarta Inc is expected to generate 0.92 times more return on investment than Avalo Therapeutics. However, Nkarta Inc is 1.09 times less risky than Avalo Therapeutics. It trades about -0.33 of its potential returns per unit of risk. Avalo Therapeutics is currently generating about -0.34 per unit of risk. If you would invest  333.00  in Nkarta Inc on August 26, 2024 and sell it today you would lose (89.00) from holding Nkarta Inc or give up 26.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Nkarta Inc  vs.  Avalo Therapeutics

 Performance 
       Timeline  
Nkarta Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nkarta Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Avalo Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Avalo Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Avalo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Nkarta and Avalo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nkarta and Avalo Therapeutics

The main advantage of trading using opposite Nkarta and Avalo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nkarta position performs unexpectedly, Avalo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avalo Therapeutics will offset losses from the drop in Avalo Therapeutics' long position.
The idea behind Nkarta Inc and Avalo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing